Research programme: echo gas liposomal - MebiopharmAlternative Names: Echo gas nano bubble - Mebiopharm; Echo gas ultrasound contrast agent - Mebiopharm; Nanoparticle contrast agent - Mebiopharm
Latest Information Update: 03 Nov 2016
At a glance
- Originator Mebiopharm; Unknown
- Developer Mebiopharm
- Class Contrast media; Diagnostic agents
- Mechanism of Action Ultrasonography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Nov 2016 No development reported for Cancer (Diagnosis) in Japan (Parenteral)